Skip to main content
SpringerLink
Log in

Are TNF inhibitors associated with malignancies in children?

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Diak P, Siegel J, La Grenade L, Choi L, Lemery S, McMahon A.Tumor necrosis factor alpha blockers and malignancy in children: forty-eight cases reported to the Food and Drug Administration. Arthritis and Rheumatism 62: 2517-2524, No. 8, Aug 2010

  2. Lehman TJA.Should the Food and Drug Administration warning of malignancy in children receiving tumor necrosis factor alph blockers change the way we treat children with juvenile idiopathic arthritis? Arthritis and Rheumatism 62: 2183-2184, No. 8, Aug 2010

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Are TNF inhibitors associated with malignancies in children?. React. Wkly. 1318, 4 (2010). https://doi.org/10.2165/00128415-201013180-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013180-00007

Keywords

Search

Navigation